Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4645 (MIR4645) is a small non-coding RNA molecule belonging to the microRNA family. MicroRNAs in general are approximately 19–25 nucleotides in length, regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs, and are involved in key cellular processes such as cell proliferation, differentiation, and apoptosis. However, there is no current information describing the biological function, disease association, or therapeutic relevance of MIR4645 specifically. The miRNA nomenclature indicates that it is a human (hsa-) microRNA, yet further functional characterization or clinical data are lacking[5][1][4][2]. In summary, MIR4645 is a microRNA but lacks specific characterization in the literature as a canonical therapeutic target, biomarker, or disease-associated molecule; consider this entry potentially incomplete or not well-supported by current biomedical sources.
No drugs act via MIR4645; microRNAs generally modulate target gene expression by base pairing with mRNA and inhibiting translation[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4645 (MIR4645).